Candel Therapeutics, Inc.
CADL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $275 | $43 | $52 | $224 |
| - Cash | $103 | $35 | $70 | $83 |
| + Debt | $13 | $23 | $23 | $1 |
| Enterprise Value | $186 | $30 | $4 | $142 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 0% | – |
| Gross Profit | -$1 | -$24 | $0 | -$14 |
| % Margin | – | – | 100% | -11,575.2% |
| EBITDA | -$52 | -$37 | -$16 | -$25 |
| % Margin | – | – | -13,046.4% | -20,395.2% |
| Net Income | -$55 | -$38 | -$19 | -$36 |
| % Margin | – | – | -15,035.2% | -28,899.2% |
| EPS Diluted | -1.74 | -1.31 | -0.099 | -1.26 |
| % Growth | -32.8% | -1,217.9% | 92.1% | – |
| Operating Cash Flow | -$27 | -$34 | -$31 | -$22 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$2 |
| Free Cash Flow | -$27 | -$35 | -$33 | -$24 |